您当前所在的位置:首页 > 产品中心 > 产品详细信息
901-47-3 分子结构
点击图片或这里关闭

methyl (2S)-5-carbamimidamido-2-(4-methylbenzenesulfonamido)pentanoate

ChemBase编号:73088
分子式:C14H22N4O4S
平均质量:342.41388
单一同位素质量:342.1361762
SMILES和InChIs

SMILES:
c1c(ccc(c1)S(=O)(=O)N[C@H](C(=O)OC)CCCNC(=N)N)C
Canonical SMILES:
COC(=O)[C@@H](NS(=O)(=O)c1ccc(cc1)C)CCCNC(=N)N
InChI:
InChI=1S/C14H22N4O4S/c1-10-5-7-11(8-6-10)23(20,21)18-12(13(19)22-2)4-3-9-17-14(15)16/h5-8,12,18H,3-4,9H2,1-2H3,(H4,15,16,17)/t12-/m0/s1
InChIKey:
FKMJXALNHKIDOD-LBPRGKRZSA-N

引用这个纪录

CBID:73088 http://www.chembase.cn/molecule-73088.html

Collapse All Expand All

名称和登记号

名称和登记号

名称 登记号
IUPAC标准名
methyl (2S)-5-carbamimidamido-2-(4-methylbenzenesulfonamido)pentanoate
IUPAC传统名
methyl (2S)-5-carbamimidamido-2-(4-methylbenzenesulfonamido)pentanoate
TAME
别名
TAME
p-TOLUENESULFONYL-L-ARGININE METHYL ESTER HYDROCHLORIDE
CAS号
901-47-3
PubChem SID
162038008
PubChem CID
1550286

数据来源

数据来源

所有数据来源 商品来源 非商品来源
数据来源 数据ID
PubChem 1550286 external link

理论计算性质

理论计算性质

JChem
Acid pKa 10.354648  质子受体
质子供体 LogD (pH = 5.5) -1.8157995 
LogD (pH = 7.4) -1.7515968  Log P 0.23181371 
摩尔折射率 96.9272 cm3 极化性 34.102673 Å3
极化表面积 134.37 Å2 可自由旋转的化学键
里宾斯基五规则 true 

分子性质

分子性质

理化性质 安全信息 药理学性质 产品相关信息 生物活性(PubChem)
熔点
147°C expand 查看数据来源
保存条件
-20°C expand 查看数据来源
MSDS下载
下载链接 expand 查看数据来源
作用靶点
APC expand 查看数据来源
成盐信息
Free Base expand 查看数据来源
质检报告
下载链接 expand 查看数据来源

详细说明

详细说明

MP Biomedicals MP Biomedicals Selleck Chemicals Selleck Chemicals
MP Biomedicals -  05218728 external link
MP Biomedicals Rare Chemical collection
Selleck Chemicals -  S2225 external link
Biological Activity
Description Tosyl-L-Arginine Methyl Ester (TAME) is an APC inhibitor.
Targets APC
IC50
In Vitro TAME inhibits cyclin proteolysis in mitotic Xenopus egg extract with IC50 of 12 μM. TAME at concentration of 1-200 μM arrests interphase extract treated with recombinant cyclin B1/Cdc2 complex in mitosis, with stable cyclin B1 and phosphorylated Cdc27. TAME at concentration of 200 μM dramaticly inhibits the ubiquitin ligase activity of the Anaphase-Promoting Complex (APC), accompanied by reduced binding of Cdh1 to APC. TAME addition to interphase extract reduces Cdc20 association with the APC in a dose-dependent manner partly by binding directly to APC, and the contribution motif is the C-terminal isoleucine-arginine (IR) tail on APC. [1] TAME is hydrolysed by trypsin with Km of 0.328 mM. [2] TAME accelerates the ATP hydrolysis process about 12-fold. [3] TAME interacts with β and γ phosphate and the adenine ring of ATP by the guanidinium group and the aromatic ring. [4] TAME at concentration of 50 mM inhibits nutrient-induced germination and pressure-induced germination at 600 MPa in Bacillus subtilis. [5] TAME induces a concentration dependent contractile response on ileal strips with EC50 of 4.3 x 103 M. [6]
In Vivo
Clinical Trials
Features
Protocol
Kinase Assay [1]
3H-TAME binding assay 3H-TAME (200 nM; 15 Ci/mmol) is added to 100 μl interphase Xenopus extract or HeLa cell lysate. APC is immunoprecipitated with Cdc27 antibody coupled to affiprep beads. The beads are washed with XB and radioactivity measured by scintillation counting. Alternatively, 3H-TAME is added and Cdc27 immunoprecipitation is performed after one or two rounds of APC immunodepletion. Specific binding is calculated as the difference between counts associated with Cdc27 antibody beads compared to beads lacking antibody (mock IP)
References
[1] Zeng X, et al. Cancer Cell, 2010, 18(4), 382-395.
[2] Khantaphant S, et al. Food Chem, 2010, 120(3), 658-664.
[3] Ma YQ, et al. J Inorg Organomet P, 2008, 18(4), 435-440.
[4] Ma Y, et al. Dalton Trans, 2008, 28(8), 1081-1086.
[5] Wuytack EY, et al. Appl Environ Microbiol, 2000, 66(1), 257-261.
[6] Subratty AH, et al. Indian J Exp Biol, 1998, 36(6), 618-621.

专利

专利

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

互联网资源

互联网资源

百度图标百度 google iconGoogle